Is PMCB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PMCB. It does not provide personalized investment advice.

PMCB (PharmaCyte Biotech, Inc. Common Stock) Stock Analysis - Financials

PharmaCyte Biotech, Inc. Common Stock (PMCB) is a publicly traded Healthcare sector company. As of July 29, 2026, PMCB trades at $0.58 with a market cap of $6.33M and a P/E ratio of 0.18. PMCB moved +0.00% today. Year to date, PMCB is -19.13%; over the trailing twelve months it is -42.60%. Its 52-week range spans $0.57 to $1.90. Rallies surfaces PMCB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PMCB's key financials?

PMCB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PMCB recently traded at $0.58. Market cap is $6.33M. P/E ratio is 0.18. Revenue is $0.

PMCB Key Metrics

Key financial metrics for PMCB
Metric	Value
Price	$0.58
Market Cap	$6.33M
P/E Ratio	0.18
EPS	$3.19
Dividend Yield	0.00%
52-Week High	$1.90
52-Week Low	$0.57
Volume	45.87K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$30.66M
Gross Margin	0.00%

PMCB Analyst Consensus

PMCB analyst coverage data. Average price target: $0.00.

Common questions about PMCB

What are PMCB's key financials?: PMCB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PMCB recently traded at $0.58. Market cap is $6.33M. P/E ratio is 0.18. Revenue is $0.
Is PMCB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PMCB. It does not provide personalized investment advice.